Literature DB >> 17043433

A case of leukemic pleural infiltration in atypical chronic myeloid leukemia.

Hyun Woo Kim1, Sung Sook Lee, Min-Hee Ryu, Jae Lyun Lee, Heung Moon Chang, Tae Won Kim, Hyun-Sook Chi, Woo Kun Kim, Jung Shin Lee, Yoon-Koo Kang.   

Abstract

Pleural effusion in chronic myeloid leukemia (CML) is poorly understood and rarely reported in the literature. When the pleural effusion is caused by leukemic pleural infiltration, the differential white blood cell count of the effusion is identical to that of the peripheral blood, and the fluid cytology reveals leukemic blasts. We report here a case of bilateral pleural involvement of atypical CML in an 83-yr old male diagnosed with pancreatic cancer with abdominal wall metastasis and incidental peripheral leukocytosis. Based on bone marrow examination, chromosome analysis and polymerase chain reaction he was diagnosed with Philadelphia chromosome negative, BCR/ABL gene rearrangement negative CML. Following 3 months of treatment with gemcitabine for pancreatic cancer, he developed bilateral pleural effusions. All stages of granulocytes and a few blasts were present in both the pleural fluid and a peripheral blood smear. After treatment with hydroxyurea and pleurodesis, the pleural effusion resolved.

Entities:  

Mesh:

Year:  2006        PMID: 17043433      PMCID: PMC2722009          DOI: 10.3346/jkms.2006.21.5.936

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  11 in total

1.  Haemopericardium with cardiac tamponade and pleural effusion in chronic myeloid leukemia.

Authors:  M K Mohapatra; S P Das; N C Mohanty; P C Dash; B K Bastia
Journal:  Indian Heart J       Date:  2000 Mar-Apr

2.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1976.

Authors: 
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

3.  Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia.

Authors:  Yavuz Beyazit; Salih Aksu; Murat Kekilli; Ibrahim C Haznedaroglu; Sadettin Kilickap; Hakan Goker
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

4.  Fine-needle aspiration biopsy of granulocytic sarcoma: a clinicopathologic study of 27 cases.

Authors:  Y K Suh; H J Shin
Journal:  Cancer       Date:  2000-12-25       Impact factor: 6.860

5.  Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate.

Authors:  Aamer Aleem; Neelam Siddiqui
Journal:  Leuk Lymphoma       Date:  2005-07

6.  Extramedullary pleural blast crisis in chronic myelogenous leukemia: cytogenetic and molecular study.

Authors:  S Sacchi; P Temperani; L Selleri; P Zucchini; S Morselli; A Vecchi; R Longo; G Torelli; G Emilia; U Torelli
Journal:  Acta Haematol       Date:  1990       Impact factor: 2.195

7.  Granulocytic sarcoma with pleural involvement. Identification of neoplastic cells with cytochemistry.

Authors:  L T Yam
Journal:  Acta Cytol       Date:  1985 Jan-Feb       Impact factor: 2.319

8.  Pleural blast crisis in chronic myelogenous leukemia.

Authors:  T I Jones
Journal:  Am J Hematol       Date:  1993-09       Impact factor: 10.047

9.  Extramedullary pleural blast crisis during otherwise chronic phase in chronic granulocytic leukaemia.

Authors:  J A Vilpo; B Dryzun; P Klemi; O Lassila; A de la Chapelle
Journal:  Eur J Cancer       Date:  1980-07       Impact factor: 9.162

Review 10.  A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature.

Authors:  M J Misialek; L Pechet
Journal:  Acta Haematol       Date:  1997       Impact factor: 2.195

View more
  1 in total

1.  Pleural effusion as the initial manifestation of chronic myeloid leukemia: Report of a case with clinical and cytologic correlation.

Authors:  Paras Nuwal; Ramakant Dixit; Prateek Dargar; Jacob George
Journal:  J Cytol       Date:  2012-04       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.